These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37112893)

  • 21. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
    J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.
    McLeod A; Hutchinson SJ; Weir A; Barclay S; Schofield J; Frew CG; Goldberg DJ; Heydtmann M; Wilson-Davies E
    Epidemiol Infect; 2022 Jun; 150():e133. PubMed ID: 35757860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project.
    Ponziani FR; Santopaolo F; Siciliano M; De Belvis AG; Tortora A; Mora V; Fanali C; Morsella A; Balducci F; Vetrugno G; D'Alfonso ME; Cambieri A; Cauda R; Bellantone R; Sanguinetti M; Pompili M; Gasbarrini A
    J Viral Hepat; 2021 Apr; 28(4):651-656. PubMed ID: 33421220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a pilot emergency department linkage to care program for patients previously diagnosed with Hepatitis C.
    Hyde Z; Roura R; Signer D; Patel A; Cohen J; Saheed M; Brinkley S; Irvin R; Sulkowski MS; Thomas DL; Rothman RE; Hsieh YH
    J Viral Hepat; 2023 Feb; 30(2):129-137. PubMed ID: 36441638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
    Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
    J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
    Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J;
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the hepatitis C virus care cascade with the in-hospital Reflex tEsting ALarm-C (REAL-C) model.
    Choi J; Park J; Choi WM; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Kwon S; Hwang SH
    Liver Int; 2024 May; 44(5):1243-1252. PubMed ID: 38375984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C reinfection by treatment pathway among people who inject drugs in Tayside, Scotland.
    Caven M; Baiano CX; Robinson EM; Stephens B; Macpherson I; Dillon JF
    J Viral Hepat; 2021 Dec; 28(12):1744-1750. PubMed ID: 34525228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
    Marukutira T; Moore KP; Hellard M; Richmond J; Turner K; Pedrana AE; Melody S; Johnston FH; Owen L; Van Den Boom W; Scott N; Thompson A; Iser D; Spelman T; Veitch M; Stoové MA; Doyle J
    BMJ Open; 2022 Mar; 12(3):e056120. PubMed ID: 35338062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
    Bregenzer A; Krismer C; Wendel S; Roser P; Fux CA
    Swiss Med Wkly; 2022 Dec; 152():40009. PubMed ID: 36509421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.
    Iversen J; Wand H; McManus H; Dore GJ; Maher L
    Addiction; 2023 May; 118(5):901-911. PubMed ID: 36524842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of hepatitis C in a hospital characterized by infectious diseases.
    Han Y; Zheng M; Meng H; Han J; Chen J; Wang Y
    Front Public Health; 2023; 11():1093578. PubMed ID: 37006527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
    Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
    Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study.
    Coupland H; Henderson C; Pritchard-Jones J; Kao SC; Sheils S; Nagy R; O'Donnell M; Haber PS; Day CA
    Harm Reduct J; 2022 May; 19(1):56. PubMed ID: 35643528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus recommendations on the management of hepatitis C in Australia's prisons.
    Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ
    Med J Aust; 2023 Mar; 218(5):231-237. PubMed ID: 36871200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
    Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J;
    Int J Drug Policy; 2022 Dec; 110():103876. PubMed ID: 36240657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia.
    Iversen J; Grebely J; Catlett B; Cunningham P; Dore GJ; Maher L
    Int J Drug Policy; 2017 Sep; 47():77-85. PubMed ID: 28578863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
    Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
    BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.
    Hsiang JC; Sinnaswami P; Lee MY; Zhang MM; Quek KE; Tan KH; Wong YM; Thurairajah PH
    Singapore Med J; 2022 Feb; 63(2):86-92. PubMed ID: 32729280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.